| 2025 | 2024 | 2022 | 2021 | 2008 | 2007 | 2006 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12,2 M € | -19.3% | 15,1 M € | — | — | — | — | — | ||||||
| Gross margin | — | — | 2,1 M € | +8.3% | 1,9 M € | +1048.7% | 166,8 k € | -5.6% | 176,6 k € | +157.4% | 68,6 k € | |||
| EBITDA | 549,6 k € | -44.7% | 993,8 k € | -47.5% | 1,9 M € | +7.6% | 1,8 M € | +961.1% | 165,7 k € | -5.6% | 175,5 k € | +160.4% | 67,4 k € | |
| Operating profit | 503,5 k € | -45.7% | 926,6 k € | -49.6% | 1,8 M € | +7.3% | 1,7 M € | +1018.8% | 153,1 k € | -3.3% | 158,3 k € | +173.2% | 57,9 k € | |
| Profit/loss | 607,6 k € | -24.8% | 808,3 k € | -41.1% | 1,4 M € | +5.7% | 1,3 M € | +1169.4% | 102,3 k € | -1.8% | 104,2 k € | +141.9% | 43,1 k € | |
| Equity | 1,2 M € | -76.3% | 5,2 M € | -0.1% | 5,2 M € | +35.8% | 3,8 M € | +1592.4% | 225,4 k € | +83.0% | 123,2 k € | -16.6% | 147,6 k € | |
| Total assets | 3,1 M € | -54.6% | 6,9 M € | +16.0% | 6,0 M € | +18.0% | 5,1 M € | +1594.9% | 299,0 k € | -7.1% | 321,7 k € | +99.9% | 160,9 k € | |
| Cash | 1,7 M € | +10.2% | 1,5 M € | -57.9% | 3,6 M € | +21.6% | 3,0 M € | +1417.7% | 195,6 k € | +56.1% | 125,4 k € | +65.5% | 75,7 k € | |
| Debts | 1,9 M € | +7.8% | 1,8 M € | +121.1% | 794,3 k € | -36.5% | 1,3 M € | +1602.7% | 73,5 k € | -63.0% | 198,5 k € | +1395.6% | 13,3 k € | |
| Staff | 3,1 | 2,7 | 2,4 | 2,6 | — | — | — | |||||||
Private limited company · Kontich · incorporated on 23/07/2003 · 3,1 ETP
Private limited company profitable and well capitalised. Cash position rising (+10.2%).
Solid counterparty for a standard engagement.
NADIMED is a Private limited company incorporated in 2003. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Kontich. It employs on average 3,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette